Alphabet 旗下 Isomorphic Labs 傳以 400 億美元估值洽談融資
Alphabet’s biolab in funding talks at $40B valuation
Alphabet 旗下 Isomorphic Labs 據報正以 400 億美元估值洽談融資,公司希望新投資可加快新藥研發。DeepSeek、Moonshot 和 OpenAI 也在尋求數十億美元新融資;專家擔心 AI 投資支出將遠超過往投資熱潮,泡沫若破裂可能造成廣泛衝擊。
Alphabet’s Isomorphic Labs is reportedly in fundraising talks at a $40 billion valuation, the latest sign of strong investor appetite for AI despite growing fears of a bubble.
The company — led by Nobel Prize winner and former Google DeepMind CEO Demis Hassabis — hopes the new investment will accelerate its push to develop new drugs.
Firms including China’s DeepSeek and Moonshot, as well as industry giant OpenAI, are also chasing billions in fresh funding as they look to stay ahead in the global AI race.
However, experts fear that the vast amount of spending on AI, which is on track to far exceed past investment booms, is creating a bubble that, were it to burst, would lead to “a far-reaching shock.”

來源:Semafor · semafor.com